Literature DB >> 11246962

Chitosan microparticles for oral vaccination: preparation, characterization and preliminary in vivo uptake studies in murine Peyer's patches.

I M van der Lubben1, J C Verhoef, A C van Aelst, G Borchard, H E Junginger.   

Abstract

Although oral vaccination has numerous advantages over parenteral injection, degradation of the vaccine in the gut and low uptake in the lymphoid tissue of the gastrointestinal tract still complicate the development of oral vaccines. In this study chitosan microparticles were prepared and characterized with respect to size, zeta potential, morphology and ovalbumin-loading and -release. Furthermore, the in vivo uptake of chitosan microparticles by murine Peyer's patches was studied using confocal laser scanning microscopy (CLSM). Chitosan microparticles were made according to a precipitation/coacervation method, which was found to be reproducible for different batches of chitosan. The chitosan microparticles were 4.3+/-0.7 microm in size and positively charged (20+/-1 mV). Since only microparticles smaller than 10 microm can be taken up by M-cells of Peyer's patches, these microparticles are suitable to serve as vaccination systems. CLSM visualization studies showed that the model antigen ovalbumin was entrapped within the chitosan microparticles and not only associated to their outer surface. These results were verified using field emission scanning electron microscopy, which demonstrated the porous structure of the chitosan microparticles, thus facilitating the entrapment of ovalbumin in the microparticles. Loading studies of the chitosan microparticles with the model compound ovalbumin resulted in loading capacities of about 40%. Subsequent release studies showed only a very low release of ovalbumin within 4 h and most of the ovalbumin (about 90%) remained entrapped in the microparticles. Because the prepared chitosan microparticles are biodegradable, this entrapped ovalbumin will be released after intracellular digestion in the Peyer's patches. Initial in vivo studies demonstrated that fluorescently labeled chitosan microparticles can be taken up by the epithelium of the murine Peyer's patches. Since uptake by Peyer's patches is an essential step in oral vaccination, these results show that the presently developed porous chitosan microparticles are a very promising vaccine delivery system.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11246962     DOI: 10.1016/s0142-9612(00)00231-3

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  32 in total

1.  Chitosan-based nanoparticles as a sustained protein release carrier for tissue engineering applications.

Authors:  Yaping Hou; Junli Hu; Hyejin Park; Min Lee
Journal:  J Biomed Mater Res A       Date:  2012-01-24       Impact factor: 4.396

2.  Controlling chitosan-based encapsulation for protein and vaccine delivery.

Authors:  Bhanu Prasanth Koppolu; Sean G Smith; Sruthi Ravindranathan; Srinivas Jayanthi; Thallapuranam K Suresh Kumar; David A Zaharoff
Journal:  Biomaterials       Date:  2014-02-21       Impact factor: 12.479

3.  Consideration of the efficacy of non-ionic vesicles in the targeted delivery of oral vaccines.

Authors:  Jitinder S Wilkhu; Sarah E McNeil; David E Anderson; Yvonne Perrie
Journal:  Drug Deliv Transl Res       Date:  2014-06       Impact factor: 4.617

4.  Application of chitosan microparticles for reduction of vibrio species in seawater and live oysters (Crassostrea virginica).

Authors:  Lei Fang; Bernhard Wolmarans; Minyoung Kang; Kwang C Jeong; Anita C Wright
Journal:  Appl Environ Microbiol       Date:  2014-11-07       Impact factor: 4.792

5.  Polymeric nanoparticles for topical delivery of alpha and beta arbutin: preparation and characterization.

Authors:  Nursyafiqah Sahrum Ayumi; Shariza Sahudin; Zahid Hussain; Mumtaz Hussain; Nor Hayati Abu Samah
Journal:  Drug Deliv Transl Res       Date:  2019-04       Impact factor: 4.617

6.  Oral Biologic Delivery: Advances Toward Oral Subunit, DNA, and mRNA Vaccines and the Potential for Mass Vaccination During Pandemics.

Authors:  Jacob William Coffey; Gaurav Das Gaiha; Giovanni Traverso
Journal:  Annu Rev Pharmacol Toxicol       Date:  2020-08-31       Impact factor: 13.820

Review 7.  Intestinal M cells: the fallible sentinels?

Authors:  Harvey Miller; Jianbing Zhang; Rhonda Kuolee; Girishchandra B Patel; Wangxue Chen
Journal:  World J Gastroenterol       Date:  2007-03-14       Impact factor: 5.742

8.  Alginate Microencapsulation for Oral Immunisation of Finfish: Release Characteristics, Ex Vivo Intestinal Uptake and In Vivo Administration in Atlantic Salmon, Salmo salar L.

Authors:  Bikramjit Ghosh; Barbara F Nowak; Andrew R Bridle
Journal:  Mar Biotechnol (NY)       Date:  2015-09-26       Impact factor: 3.619

9.  Formulation and characterization of a plasma sterilized, pharmaceutical grade chitosan powder.

Authors:  Andrew R Crofton; Samuel M Hudson; Kristy Howard; Tyler Pender; Abdelrahman Abdelgawad; Daniel Wolski; Wolff M Kirsch
Journal:  Carbohydr Polym       Date:  2016-03-06       Impact factor: 9.381

10.  Transport of chitosan-DNA nanoparticles in human intestinal M-cell model versus normal intestinal enterocytes.

Authors:  Irina Kadiyala; Yihua Loo; Krishnendu Roy; Janet Rice; Kam W Leong
Journal:  Eur J Pharm Sci       Date:  2009-11-12       Impact factor: 4.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.